Skip to main content

Antivenin Procedure Code J0841 (ANAVIP®) to Become a Medicaid Benefit Effective June 1, 2022

Last updated on 5/20/2022

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to eligible clients. Administrative procedures such as prior authorization, precertification, referrals, and claims/encounter data filing may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the client's specific MCO for details.

Effective for dates of service on or after June 1, 2022, antivenin procedure code J0841 (ANAVIP®) will become a benefit of Texas Medicaid.

ANAVIP® is an antivenin approved for use in adults and children with North American Pit Viper envenomation.

Procedure code J0841 may be reimbursed for the following places of service and provider types:

Place of Service

Provider Type

Office

Physician assistants, nurse practitioners, clinical nurse specialists, and physicians

Outpatient hospital

Hospital providers

Details are available on the TMHP website at www.tmhp.com.

For more information, call the TMHP Contact Center at 800-925-9126.